Literature DB >> 4674399

The assessment of drug-dependent and isoimmune antiplatelet antibodies by the use of platelet aggregometry.

D Deykin, L J Hellerstein.   

Abstract

The technique of platelet aggregometry provides a simple, quantitative, and specific method for the detection of drug-dependent and isoimmune antiplatelet antibodies. In the presence of antiquinidine antibody, quinidine causes lysis of normal platelets in platelet-rich plasma. The resulting changes in optical density are readily detected in the aggregometer. The initial rate of lysis is a function of the antibody titer, but is relatively independent of the platelet count. In vitro, quinidine produces platelet swelling and inhibits aggregation of platelets by adenosine diphosphate, epinephrine, and collagen. Isoimmune antibodies cause aggregation of platelets in platelet-rich plasma. In studies of a single family the rate of aggregation is proportional to the number of HL-A antigens present on the normal platelets against which the antibody is directed. The simple technique of platelet aggregometry may be a useful adjunct in the selection of compatible donors for platelet transfusion. Serum derived from patients with idiopathic thromboytopenic purpura did not cause platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4674399      PMCID: PMC332996          DOI: 10.1172/JCI107141

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Effect of anti-platelet antibodies on the in vitro uptake of 5-hydroxytryptamine by blood platelets.

Authors:  J M BRIDGES; M BALDINI; C FICHERA; W DAMESHEK
Journal:  Nature       Date:  1963-01-26       Impact factor: 49.962

2.  Rapid diagnosis of drug-induced thrombocytopenic purpura. Report of three cases due to quinine, quinidine, and Dilantin.

Authors:  R M WEINTRAUB; L PECHET; B ALEXANDER
Journal:  JAMA       Date:  1962-05-19       Impact factor: 56.272

3.  Immune platelet isoantibodies.

Authors:  J DAUSSET; M COLIN; J COLOMBANI
Journal:  Vox Sang       Date:  1960-02       Impact factor: 2.144

4.  Identification and significance of platelet antibodies.

Authors:  J L TULLIS
Journal:  N Engl J Med       Date:  1956-09-20       Impact factor: 91.245

5.  The cause of thrombocytopenia in sedormid purpura.

Authors:  J F ACKROYD
Journal:  Clin Sci       Date:  1949-12-19       Impact factor: 6.124

6.  Importance of histocompatibility in platelet transfusion therapy.

Authors:  R A Yankee
Journal:  Vox Sang       Date:  1971-05       Impact factor: 2.144

7.  Release of vasoactive amines from rabbit platelets induced by antiplatelet antibody in the presence and absence of complement.

Authors:  P M Henson
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

8.  Colchicine-binding protein from human platelets and its effect on muscle myosin and platelet myosin-like thrombosthenin-M.

Authors:  E Puszkin; S Puszkin; L M Aledort
Journal:  J Biol Chem       Date:  1971-01-25       Impact factor: 5.157

9.  Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function.

Authors:  J G White
Journal:  Am J Pathol       Date:  1968-08       Impact factor: 4.307

10.  Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.

Authors:  N R Shulman; V J Marder; R S Weinrach
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

View more
  6 in total

1.  Hyperaggregation effect in idiopathic thrombocytopenia and multiple transfused patients.

Authors:  N Wagner; T J Degnan
Journal:  J Clin Pathol       Date:  1973-09       Impact factor: 3.411

2.  Bitter lemon purpura.

Authors:  J A Murray; I Abbott; D A Anderson; A D Morgan
Journal:  Br Med J       Date:  1979-12-15

3.  Heterogeneity of antibody response to human platelet transfusion.

Authors:  K K Wu; J S Thompson; J A Koepke; J C Hoak; R Flink
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

Review 4.  Heparin Therapy: regimens and management.

Authors:  D Deykin
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

5.  Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal mucosal origin.

Authors:  I D Malcolm; T A Wigmore; U P Steinbrecher
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

6.  Detection of anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP) and in patients with rubella and herpes group viral infections.

Authors:  S Kahane; A Dvilansky; L Estok; I Nathan; Z Zolotov; I Sarov
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.